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A new DNA polymerase and DNase activity were identified from cells infected with human B-lymphotropic
herpesvirus (HBLV). DNA polymerase associated with HBLV infection was similar in its sensitivity to
inhibition by ppi analogs as other herpesvirus-specific DNA polymerases but was dissimilar in its inhibition by
certain nucleoside triphosphates.
In recent years, several human viruses have been identi-
fied and related to a number of human diseases. Human B-
lymphotropic virus (HBLV), a novel herpesvirus, was iso-
lated from cultured human mononuclear cells from patients
with lymphoproliferative diseases. Based on its ability to
infect freshly isolated B lymphocytes, this virus was desig-
nated HBLV (15, 25). This virus can also infect several
non-B types of human tissue culture cells (1). HBLV was
morphologically classified as a herpesvirus on the basis of
the icosahedral symmetry of the isolated virions and since it
contained double-stranded DNA greater than 110 kilobases
(3, 15, 25). The failure of HBLV DNA to hybridize to the
genomic probes of other herpesvirus DNAs and vice versa
clearly indicates that HBLV is a novel herpesvirus (25).
Although no human diseases have so far been associated
with HBLV, it is of interest to study the biochemistry and
enzymology of this virus since very little of its biology is
known. This information could aid in understanding more
about this herpesvirus, identifying diseases which may be
associated with HBLV, and identifying potential antiviral
compounds should HBLV be linked to a specific disease.
All identified human herpesviruses such as herpes simplex
virus type 1 or 2 (HSV-1 or -2) (10, 13, 17, 18, 23),
Epstein-Barr virus (EBV) (22, 26), cytomegalovirus (CMV)
(14), and varicella-zoster virus (8) are capable of inducing
virally coded enzymes such as DNA polymerase and DNase
in cells infected with these viruses. In this report, we present
evidence that the infection of HSB-2 (a T-cell line) by HBLV
also leads to the induction of DNA polymerase and DNase.
The DNA polymerase induced by HBLV shares some of the
properties of DNA polymerases induced by other human
herpesviruses. However, it also has some unique features
which distinguish it from other herpesvirus DNA polymer-
ases.
HSB-2, a cell line susceptible to infection with HBLV
(obtained from the American Type Culture Collection,
Rockville, Md.) was used for this study. Infections were
initiated by adding HBLV-infected HSB-2 cells to unin-
fected cells at a ratio of 1:20 (infected-uninfected). The cells
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were harvested 5 days postinfection, washed, and stored at
-70°C. The infected cell pellet was freeze-thawed and then
extracted with 500 ,ul of 100 mM Tris chloride (pH 7.5)
containing 300 mM KCI (all buffers contained 2 mM EDTA,
2 mM dithiothreitol, 2 mM phenylmethylsulfonyl fluoride,
and 20% glycerol; all procedures were done at 4°C). The
solution was allowed to stand on ice for 15 min and then
centrifuged. The crude cell extract thus obtained was used
for the enzyme assays. DNA polymerase assays were per-
formed according to published procedures (9). DNA poly-
merase was assayed in the presence and absence of salt to
distinguish between virus-induced and host DNA polymer-
ase. One unit of DNA polymerase activity is defined as the
amount of enzyme that catalyzed the incorporation of 1 pmol
of dTTP per min into acid-insoluble product under the assay
conditions. The concentrations of the inhibitors and the
appropriate nucleotides were varied during the kinetic anal-
yses, and 2 units of enzyme were used in each assay. The Km
and Ki values were determined by the linear regression
method. DNase assays were performed by published meth-
ods (7). This assay is capable of detecting alkaline DNase as
well as virus-induced DNA polymerase-associated exonu-
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FIG. 1. Profile of the DNA polymerase and DNase activities
following infection of HSB-2 cells with HBLV-infected HSB-2 cells
(cocultivation, 20:1). POL, Polymerase; PFA, phosphonoformate.
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TABLE 1. K,, values of substrates for different
DNA polymerases
K,,, (,M)
Substrate Human" HSV-1 HSV-2 CMV EBV
(KOS)" (333)" (Towne)' (HR-i) HBLV
dATP 3.8 0.4 0.2 1.5 2.5 1.3 (± 0.15)
dGTP 6.0 0.2 0.2 0.5 0.7 0.1 (± 0.11)
dCTP 3.1 2.4 0.5 0.1 0.6 0.5 0.8 (± 0.23)
dTTP 7.0 8.6 0.5 0.2 0.6 0.5 0.8 (± 0.08)




cells were utilized, and to purify DNA polymerase, 1.6 x 108
infected cells were used.
The newly identified human herpesvirus HBLV, like other
herpesviruses, was capable of inducing activities of DNA
polymerase and DNase in infected cells (Fig. 1). In the
mock-infected cells, there was no significant alteration of
these enzyme activities through the time period studied (data
not shown). The induction of the DNA polymerase and
DNase activities correlated with the appearance of the
HBLV-induced cytopathic effects.
To purify HBLV DNA polymerase, we mixed the crude
extract with 3 ml of prewashed and preequilibrated (with 400
mM phosphate, pH 7.5) DEAE-cellulose. The slurry was
mixed well and centrifuged. The supernatant was saved, and
the resin was washed with 1 ml of 400 mM phosphate buffer
and centrifuged, and this supernatant was saved. This was
repeated two more times. The pooled supernatants were
dialyzed against 25 mM phosphate (pH 7.5) and loaded onto
a 15-ml DEAE-cellulose column (preequilibrated with the
dialysis buffer). After the column was washed, it was eluted
with a linear phosphate gradient (50 mM to 1 M). The
fractions containing DNA polymerase activity (eluted at 0.45
M phosphate) were pooled, dialyzed, and loaded onto a
10-ml double-stranded DNA-cellulose column (preequili-
brated with the dialysis buffer) and then eluted with a linear
salt (KCl) gradient (0 to 1 M). The fractions containing DNA
polymerase (eluted at 0.55 M KCl) were pooled and stabi-
lized by dialysis against 50 mM HEPES (N-2-hydroxyeth-
ylpiperazine-N'-2-ethanesulfonic acid) (pH 7.5) buffer con-
taining 30% sucrose and 20% ethylene glycol. Heat-inacti-
vated bovine serum albumin (final concentration, 100 ,ug/ml)
was added to the enzyme solution before dialysis. The
DNase activity coeluted with DNA polymerase from DEAE-
cellulose. However, we were unable to detect the activity in
fractions obtained from the double-stranded DNA-cellulose
column. Nearly a 200-fold purification of DNA polymerase
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FIG. 2. Determination of the effect of salt (potassium chloride)
(A) and pH optimum (B) of the HBLV-induced DNA polymerase
activity. The salt was added to the reaction mix (pH 8) to give the
desired concentration.
was achieved by this scheme, as determined by its specific
activity.
HBLV-induced DNA polymerase showed maximum stim-
ulation of its activity at approximately 175 mM salt concen-
tration, and its pH optimum appeared to be in the range of
7.7 to 8.0 (Fig. 2). On the other hand, host DNA polymerase
(a) was inhibited by the salt, even at 100 mM. PP,, analogs
such as phosphonoformic acid and phosphonoacetic acid
were capable of inhibiting this activity (50% inhibitory
doses, 0.4 and 2.54 ,uM, respectively). All these properties
were similar to those exhibited by other human herpesvi-
ruses-induced DNA polymerases (16, 19). The K,,, values for
its substrates were also determined, and although they
appeared to be slightly higher than those for other herpesvi-
rus-induced DNA polymerases, they were still much lower
than substrate K,,n values for human DNA polymerases
(Table 1). Thus, like other herpesviruses, HBLV-induced
DNA polymerase appears to be more efficient than host
enzymes in competing for the nucleotides required for DNA
synthesis.
The ability of HBLV-induced DNA polymerase to utilize
different types of DNA templates was investigated. This
enzyme failed to use synthetic templates (final concentra-
tion; 0.5 U/ml) such as poly(rA) oligo(dT)12_18, poly(dG)
oligo(dC)12-18, and poly(dC) oligo(dG)10. However, HBLV-
induced DNA polymerase utilized poly(dA) oligo(dT)12_18
as a template (90% activity compared with activated calf
thymus DNA). Activated, but not native or denatured, calf
thymus DNA (final concentration, 40 ,ug/ml) could serve as a
template (100% activity represents 28 pmol of incorporated
[3H]TTP). DNA polymerases induced by CMV (14) and
TABLE 2. Kj values of deoxynucleoside triphosphate analogs toward HBLV and other DNA polymerases
Ki (,uM)
Analog Competing Human" HSV-1 HSV-2 CMV EBV HBLV~substrate HSV_1SV_2____EV_HBL
a a (KOS)" (333)" (Towne)" (HR-1)"
ACV-TPb dGTP 0.2 0.003 0.003 0.008 0.01 2.5 (± 0.35)
DHPG-TPb dGTP 0.12 0.030 0.046 0.022 0.075 0.13 (± 0.05)
BVdU-TPb dTTP 3.6 6.5 0.068 0.068 0.25 (± 0.04)
Aphidicolin dCTP 1.3 0.071 0.5 (± 0.15)
" Reference 10.
b 5'-Triphosphate form of ACV, DHPG. and BVdU.
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TABLE 3. Inhibition of HBLV DNA polymerase by
triphosphates of various nucleoside analogs
Inhibitor (FM) Competing nucleotide % Inhibition'(0.625 p.M)
3'-N3TTPb (2) dTTP 27
BVdU-TP (6) dTTP 90
Acyclo ATP (6) dATP 78
ddATP (6) dATP 7
5-Fluoro-ara-CTP (6) dCTP 55
ddCTP (6) dCTP 15
ddGTP (6) dGTP 13
DHPG-TP (5) dGTP 76
ACV-TP (5) dGTP 45
a The values represent the percent inhibition of the control, which con-
tained no inhibitor and incorporated 28 pmol of [3H]TTP in 30 min.
b 3'-N3TTP, 3'-Azido-2'-dTTP.
EBV (16) share some of the properties with HBLV-induced
enzymes.
The interaction of the triphosphates of several known
antiviral nucleoside analogs (2, 5, 6, 8, 12, 24) with HBLV-
induced DNA polymerase was examined (Table 2). The
triphosphates of 9-(2-hydroxyethoxymethyl)guanine (ACV),
9-(3,1-dihydroxy-2-propoxymethyl)guanine (DHPG), and
(E)-5-(2-bromovinyl)-2-deoxyuridine (BVdU) were observed
to be competitive inhibitors of this enzyme with respect to
dGTP, dGTP, and dTTP, respectively. The Ki values were
quite different from those of other herpesvirus-induced DNA
polymerases. Conversely, dideoxynucleotides such as
ddATP, ddCTP, and ddTTP, which are potent inhibitors of
reverse transcriptases (4, 11, 21), were found to be poor
inhibitors of HBLV-induced DNA polymerase (Table 3).
HBLV-induced DNA polymerase, like HSV-1 and HSV-2
(9)- and EBV (20)-induced DNA polymerase was also inhib-
ited by aphidicolin, and the inhibition appeared to be com-
petitive with dCTP. Based on the Ki value for ACV-TP
(ACV 5'-triphosphate) and its ratio to the Km value for
dGTP, ACV may not be as selective against HBLV as it is
against other herpesviruses such as EBV, whereas DHPG
and BVdU may be more selective inhibitors of HBLV
replication. At present, this is under investigation.
The properties described above indicate that the DNA
polymerase induced by HBLV, a newly identified human
herpesvirus, shares some properties with DNA polymerases
induced by other herpesviruses. This suggests that the
structures of DNA polymerases induced by known human
herpesviruses are conserved. However, there exist several
differences which distinguish between DNA polymerase
induced by HBLV and those induced by other herpesvi-
ruses, and these differences could be utilized to differentiate
different types of herpesviruses. Furthermore, the differ-
ences in the properties of this enzyme from the host enzymes
could also be explored for developing selective anti-HBLV
compounds, should a disease related to HBLV infection be
identified. Although the enzyme obtained was not com-
pletely purified, the results suggest that HBLV-induced
DNA polymerase is different from other herpesvirus-in-
duced DNA polymerases. Therefore, further characteriza-
tion is warranted.
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